Show content

Home

NCI-MATCH Trial (Molecular Analysis for Therapy Choice)

Information about the NCI-MATCH precision medicine trial, in which patients with advanced solid tumors and lymphomas are assigned to treatment arms based on the molecular profiles of their disease.

Media Type: Html

SourceUrl: https://www.cancer.gov/publishedcontent/syndication/829631.htm
Syndication ID: 19727
Language: English
Source: National Cancer Institute (NCI)
Date Syndication Captured: Monday, March 23, 2020 at 07:15 PM
Date Syndication Updated: Friday, May 14, 2021 at 09:15 AM

0 Users liked this content.

Embed Code Snippet

To get the embed code snippet please Login.